Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy
Johnson, D. B., Wallender, E. K., Cohen, D. N., Likhari, S. S., Zwerner, J. P., Powers, J. G., Shinn, L., Kelley, M. C., Joseph, R. W., Sosman, J. A.Volume:
1
Language:
english
Journal:
Cancer Immunology Research
DOI:
10.1158/2326-6066.CIR-13-0092
Date:
December, 2013
File:
PDF, 838 KB
english, 2013